值得注意的是，董事会建议于合并生效时间后，将公司英文名称由“Genor Biopharma Holdings Limited”更改为“Edding Genor Group Holdings Limited”，并将公司的双重外文中文名称由“嘉和生物药业（开曼）控股有限公司”更改为“亿腾嘉和医药集团有限公司”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.